Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ERG
|
ENSG00000157554.14 | ETS transcription factor ERG |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERG | hg19_v2_chr21_-_40032581_40032605 | 0.07 | 7.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51875894 | 12.89 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr8_-_133772794 | 11.37 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr4_+_153021899 | 11.01 |
ENST00000509332.1
ENST00000504144.1 ENST00000499452.2 |
RP11-18H21.1
|
RP11-18H21.1 |
chr14_-_106830057 | 10.79 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr10_-_72362515 | 10.61 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr16_-_30393752 | 9.92 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
chr8_-_133772870 | 9.61 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr16_+_30484054 | 9.43 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr22_-_37640456 | 9.37 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr16_+_30483962 | 9.30 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr8_-_21771214 | 9.08 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
chr1_+_32716840 | 9.08 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr22_+_23165153 | 8.91 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr1_-_167487808 | 8.85 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
chr1_-_167487758 | 8.75 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr1_+_32716857 | 8.64 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr7_-_3083573 | 8.55 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr16_+_29674277 | 8.54 |
ENST00000395389.2
|
SPN
|
sialophorin |
chr7_+_50348268 | 8.46 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr11_+_60223312 | 8.41 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr14_+_22392209 | 8.35 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr19_+_42381337 | 8.15 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr14_+_22475742 | 8.05 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
chr5_-_176937351 | 8.01 |
ENST00000377112.4
ENST00000501403.2 ENST00000312943.6 |
DOK3
|
docking protein 3 |
chr3_-_183273477 | 7.96 |
ENST00000341319.3
|
KLHL6
|
kelch-like family member 6 |
chr3_+_108541545 | 7.86 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr11_-_118122996 | 7.83 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
chr1_-_161039456 | 7.80 |
ENST00000368016.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr14_-_106114739 | 7.71 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr16_+_32859034 | 7.69 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
chr1_+_153330322 | 7.69 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr16_-_29757272 | 7.65 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
chr22_+_23054174 | 7.62 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr1_-_153518270 | 7.55 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr17_-_76123101 | 7.50 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr1_-_36937075 | 7.48 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr2_-_219031709 | 7.47 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
chr3_+_108541608 | 7.45 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr19_+_42381173 | 7.39 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr4_+_40198527 | 7.37 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr16_+_30484021 | 7.36 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr19_-_10450287 | 7.36 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr17_+_38673270 | 7.17 |
ENST00000578280.1
|
RP5-1028K7.2
|
RP5-1028K7.2 |
chr19_-_10450328 | 7.16 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr11_+_63974135 | 7.14 |
ENST00000544997.1
ENST00000345728.5 ENST00000279227.5 |
FERMT3
|
fermitin family member 3 |
chr19_+_3178736 | 7.06 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
chr2_+_218994002 | 7.06 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
chr6_+_31553901 | 6.97 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr21_-_46340770 | 6.94 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr12_-_57871620 | 6.93 |
ENST00000552604.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr17_+_72462766 | 6.91 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr15_+_81589254 | 6.88 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr14_+_21423611 | 6.86 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
chr22_-_37880543 | 6.82 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr1_+_209929494 | 6.80 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr2_+_103035102 | 6.75 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr1_+_209929377 | 6.74 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr6_-_31550192 | 6.74 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr10_+_81370689 | 6.74 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
chr11_+_60223225 | 6.74 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr9_-_117150243 | 6.73 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
chr22_+_27068766 | 6.68 |
ENST00000435162.1
ENST00000437071.1 ENST00000440816.1 ENST00000421253.1 |
CTA-211A9.5
|
CTA-211A9.5 |
chr12_-_57871567 | 6.66 |
ENST00000551452.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr1_-_207095212 | 6.60 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr14_+_88471468 | 6.57 |
ENST00000267549.3
|
GPR65
|
G protein-coupled receptor 65 |
chr22_+_23222886 | 6.51 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr4_-_48082192 | 6.48 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
chr12_+_9142131 | 6.47 |
ENST00000356986.3
ENST00000266551.4 |
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr21_+_43823983 | 6.47 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
chr12_-_57871825 | 6.43 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr10_-_81320151 | 6.38 |
ENST00000372325.2
ENST00000372327.5 ENST00000417041.1 |
SFTPA2
|
surfactant protein A2 |
chr22_+_44577237 | 6.35 |
ENST00000415224.1
ENST00000417767.1 |
PARVG
|
parvin, gamma |
chr12_-_9760482 | 6.34 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
chr4_-_74864386 | 6.32 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr19_+_7413835 | 6.29 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
chr22_+_23247030 | 6.27 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr7_-_45018686 | 6.23 |
ENST00000258787.7
|
MYO1G
|
myosin IG |
chr16_+_57702099 | 6.17 |
ENST00000333493.4
ENST00000327655.6 |
GPR97
|
G protein-coupled receptor 97 |
chr8_-_21771182 | 6.14 |
ENST00000523932.1
ENST00000544659.1 |
DOK2
|
docking protein 2, 56kDa |
chr17_-_62009621 | 6.11 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr12_-_57871853 | 6.11 |
ENST00000549602.1
ENST00000430041.2 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chr17_-_6983550 | 6.10 |
ENST00000576617.1
ENST00000416562.2 |
CLEC10A
|
C-type lectin domain family 10, member A |
chr5_-_39274617 | 6.06 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
chr15_+_75074410 | 5.99 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr19_+_55141861 | 5.98 |
ENST00000396327.3
ENST00000324602.7 ENST00000434867.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr11_+_1874200 | 5.97 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr15_+_77287426 | 5.97 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr6_+_106534192 | 5.95 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr10_+_49892904 | 5.94 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
chr1_-_167059830 | 5.90 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
chr1_+_158901329 | 5.90 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr6_-_32160622 | 5.89 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr20_-_1569278 | 5.84 |
ENST00000262929.5
ENST00000567028.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
chr11_-_118083600 | 5.84 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr11_+_67171391 | 5.84 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr11_+_118175132 | 5.80 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chr14_-_106406090 | 5.80 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr2_-_136873735 | 5.77 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr1_+_206730484 | 5.77 |
ENST00000304534.8
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chr11_+_67171358 | 5.75 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr1_+_209929446 | 5.73 |
ENST00000479796.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr16_+_57702210 | 5.71 |
ENST00000450388.3
|
GPR97
|
G protein-coupled receptor 97 |
chr1_-_111746966 | 5.70 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr1_+_203734296 | 5.69 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
chr19_+_7733929 | 5.69 |
ENST00000221515.2
|
RETN
|
resistin |
chr22_+_27068704 | 5.67 |
ENST00000444388.1
ENST00000450963.1 ENST00000449017.1 |
CTA-211A9.5
|
CTA-211A9.5 |
chr3_+_111260980 | 5.67 |
ENST00000438817.2
|
CD96
|
CD96 molecule |
chr1_-_207095324 | 5.66 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr21_-_46340884 | 5.62 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr16_+_67678818 | 5.61 |
ENST00000334583.6
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
chr6_+_31553978 | 5.60 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr11_+_67171548 | 5.60 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr19_-_51875523 | 5.59 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
chr22_-_37545972 | 5.57 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
chr21_-_46340807 | 5.56 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr3_+_111260856 | 5.54 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr14_+_22409308 | 5.52 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
chr14_-_106586656 | 5.48 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr3_+_111260954 | 5.47 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr12_-_57873329 | 5.46 |
ENST00000424809.2
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr3_+_46395219 | 5.45 |
ENST00000445132.2
ENST00000292301.4 |
CCR2
|
chemokine (C-C motif) receptor 2 |
chrX_-_153192211 | 5.43 |
ENST00000461052.1
ENST00000422091.1 |
ARHGAP4
|
Rho GTPase activating protein 4 |
chr15_-_40600111 | 5.40 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
chr14_+_22520762 | 5.35 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
chr17_+_76126842 | 5.35 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
chr1_+_32739733 | 5.33 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr12_+_10103893 | 5.33 |
ENST00000355690.4
|
CLEC12A
|
C-type lectin domain family 12, member A |
chr14_+_22458631 | 5.31 |
ENST00000390444.1
|
TRAV16
|
T cell receptor alpha variable 16 |
chr8_-_126963387 | 5.30 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr12_+_69742121 | 5.27 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr22_-_37640277 | 5.24 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_+_209941942 | 5.19 |
ENST00000487271.1
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr9_-_117150303 | 5.19 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
chr12_-_57873631 | 5.16 |
ENST00000393791.3
ENST00000356411.2 ENST00000552249.1 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chr4_+_102711764 | 5.16 |
ENST00000322953.4
ENST00000428908.1 |
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
chr1_+_32739714 | 5.15 |
ENST00000461712.2
ENST00000373562.3 ENST00000477031.2 ENST00000373557.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr1_-_157789850 | 5.12 |
ENST00000491942.1
ENST00000358292.3 ENST00000368176.3 |
FCRL1
|
Fc receptor-like 1 |
chr16_-_30394143 | 5.11 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
chr14_-_100842588 | 5.08 |
ENST00000556645.1
ENST00000556209.1 ENST00000556504.1 ENST00000556435.1 ENST00000554772.1 ENST00000553581.1 ENST00000553769.2 ENST00000554605.1 ENST00000557722.1 ENST00000553413.1 ENST00000553524.1 ENST00000358655.4 |
WARS
|
tryptophanyl-tRNA synthetase |
chr4_+_102711874 | 5.08 |
ENST00000508653.1
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
chr4_+_2814011 | 5.07 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr5_-_138861926 | 5.07 |
ENST00000510817.1
|
TMEM173
|
transmembrane protein 173 |
chr9_-_137809718 | 5.05 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr5_-_138862326 | 5.03 |
ENST00000330794.4
|
TMEM173
|
transmembrane protein 173 |
chr15_+_77287715 | 5.02 |
ENST00000559161.1
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr19_+_36393367 | 5.01 |
ENST00000246551.4
|
HCST
|
hematopoietic cell signal transducer |
chr7_+_142000747 | 4.97 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr22_+_37257015 | 4.97 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr11_-_64512273 | 4.95 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chrY_+_2709906 | 4.94 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr2_+_231090471 | 4.94 |
ENST00000373645.3
|
SP140
|
SP140 nuclear body protein |
chr19_-_6481759 | 4.94 |
ENST00000588421.1
|
DENND1C
|
DENN/MADD domain containing 1C |
chr1_-_161039647 | 4.93 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chrY_+_2709527 | 4.93 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chrX_-_70331298 | 4.93 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr5_+_35856951 | 4.87 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr4_+_100737954 | 4.86 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr2_+_231090433 | 4.84 |
ENST00000486687.2
ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140
|
SP140 nuclear body protein |
chr19_-_54804173 | 4.84 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
chr16_+_28996114 | 4.84 |
ENST00000395461.3
|
LAT
|
linker for activation of T cells |
chr17_-_42466864 | 4.83 |
ENST00000353281.4
ENST00000262407.5 |
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
chr7_-_3083472 | 4.83 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
chr17_-_62009702 | 4.82 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr14_-_107083690 | 4.80 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr4_-_153601136 | 4.79 |
ENST00000504064.1
ENST00000304385.3 |
TMEM154
|
transmembrane protein 154 |
chr1_-_155990580 | 4.78 |
ENST00000531917.1
ENST00000480567.1 ENST00000526212.1 ENST00000529008.1 ENST00000496742.1 ENST00000295702.4 |
SSR2
|
signal sequence receptor, beta (translocon-associated protein beta) |
chr16_+_67679069 | 4.77 |
ENST00000545661.1
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
chr1_-_32687923 | 4.77 |
ENST00000309777.6
ENST00000344461.3 ENST00000373593.1 ENST00000545122.1 |
TMEM234
|
transmembrane protein 234 |
chr11_-_67205538 | 4.76 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
chr14_-_106878083 | 4.76 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr22_+_39378375 | 4.75 |
ENST00000402182.3
ENST00000333467.3 |
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
chr1_+_32687971 | 4.75 |
ENST00000373586.1
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I |
chr15_+_75074385 | 4.74 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
chr10_-_98480243 | 4.72 |
ENST00000339364.5
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
chr1_+_198607801 | 4.71 |
ENST00000367379.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr2_+_202098203 | 4.71 |
ENST00000450491.1
ENST00000440732.1 ENST00000392258.3 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr17_-_37934466 | 4.71 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr12_+_7055767 | 4.69 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_31560729 | 4.68 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr1_-_92952433 | 4.65 |
ENST00000294702.5
|
GFI1
|
growth factor independent 1 transcription repressor |
chr17_+_7239904 | 4.64 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr19_+_544034 | 4.62 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
chr14_-_107095662 | 4.61 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr8_-_21771173 | 4.61 |
ENST00000518197.1
|
DOK2
|
docking protein 2, 56kDa |
chrX_+_64808248 | 4.58 |
ENST00000609672.1
|
MSN
|
moesin |
chr20_+_31870927 | 4.58 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
chr3_+_113251143 | 4.58 |
ENST00000264852.4
ENST00000393830.3 |
SIDT1
|
SID1 transmembrane family, member 1 |
chr1_+_160765919 | 4.57 |
ENST00000341032.4
ENST00000368041.2 ENST00000368040.1 |
LY9
|
lymphocyte antigen 9 |
chr19_+_36393422 | 4.57 |
ENST00000437550.2
|
HCST
|
hematopoietic cell signal transducer |
chr16_+_28996416 | 4.56 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
chr3_+_114012819 | 4.56 |
ENST00000383671.3
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains |
chr14_+_22931924 | 4.56 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
chr19_+_55141948 | 4.53 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr1_+_209941827 | 4.51 |
ENST00000367023.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr14_-_106478603 | 4.51 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chrX_+_128913906 | 4.50 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr16_+_28996364 | 4.48 |
ENST00000564277.1
|
LAT
|
linker for activation of T cells |
chr1_+_198608146 | 4.47 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr20_+_24929866 | 4.47 |
ENST00000480798.1
ENST00000376835.2 |
CST7
|
cystatin F (leukocystatin) |
chr17_-_29641104 | 4.46 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.7 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
5.2 | 20.7 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
4.4 | 13.1 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
3.6 | 18.2 | GO:0039513 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
3.3 | 3.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
3.2 | 12.8 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
3.0 | 8.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.7 | 51.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.6 | 2.6 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
2.5 | 10.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
2.5 | 7.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.4 | 7.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.4 | 14.5 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
2.4 | 7.2 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
2.3 | 6.9 | GO:0061485 | memory T cell proliferation(GO:0061485) |
2.3 | 6.9 | GO:0071258 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.3 | 6.9 | GO:2000283 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
2.2 | 15.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.2 | 48.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.1 | 2.1 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.1 | 6.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.1 | 6.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
2.0 | 40.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
2.0 | 6.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
2.0 | 10.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.0 | 6.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
1.9 | 5.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
1.9 | 3.8 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.9 | 5.6 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.8 | 7.4 | GO:0002467 | germinal center formation(GO:0002467) |
1.8 | 8.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.8 | 3.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.7 | 5.2 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
1.7 | 17.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.7 | 11.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.7 | 15.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.6 | 6.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.6 | 4.9 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.6 | 4.8 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.6 | 1.6 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.6 | 4.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
1.5 | 12.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
1.5 | 4.4 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
1.5 | 2.9 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.4 | 5.7 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
1.4 | 9.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.4 | 9.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.4 | 9.6 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.4 | 5.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.3 | 14.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.3 | 4.0 | GO:0019085 | early viral transcription(GO:0019085) |
1.3 | 6.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.3 | 10.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.3 | 6.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.3 | 5.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
1.3 | 3.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.2 | 6.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.2 | 1.2 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
1.2 | 2.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.2 | 10.7 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
1.2 | 7.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 5.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.2 | 3.5 | GO:1900098 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
1.2 | 4.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.2 | 8.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.2 | 4.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.1 | 8.0 | GO:0032252 | secretory granule localization(GO:0032252) |
1.1 | 3.4 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
1.1 | 3.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.1 | 9.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.1 | 5.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.1 | 25.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.1 | 7.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.1 | 4.3 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.1 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
1.0 | 2.1 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.0 | 8.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.0 | 3.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
1.0 | 3.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.0 | 2.0 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
1.0 | 4.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
1.0 | 1.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.0 | 6.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 3.0 | GO:0021503 | neural fold bending(GO:0021503) |
1.0 | 4.9 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.0 | 13.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.0 | 11.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 1.0 | GO:1901655 | cellular response to ketone(GO:1901655) |
1.0 | 9.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.0 | 1.9 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.0 | 7.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.9 | 3.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.9 | 0.9 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 2.8 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.9 | 6.5 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.9 | 4.6 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.9 | 3.7 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.9 | 12.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.9 | 4.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.9 | 0.9 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.9 | 14.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 0.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 2.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.9 | 17.8 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.9 | 8.9 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.9 | 4.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.9 | 2.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.9 | 5.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.9 | 2.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.9 | 2.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.9 | 4.4 | GO:0032796 | uropod organization(GO:0032796) |
0.9 | 5.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.9 | 0.9 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.9 | 17.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.9 | 4.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.9 | 0.9 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.8 | 5.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.8 | 5.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.8 | 5.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.8 | 1.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.8 | 4.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.8 | 1.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.8 | 2.4 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.8 | 3.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.8 | 1.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.8 | 12.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 7.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.8 | 2.3 | GO:1990868 | beta selection(GO:0043366) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.7 | 6.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.7 | 10.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 3.7 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.7 | 16.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.7 | 2.9 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.7 | 4.4 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.7 | 2.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.7 | 5.1 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.7 | 1.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.2 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.7 | 3.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 1.4 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.7 | 4.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.7 | 5.0 | GO:2000782 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.7 | 10.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.7 | 0.7 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
0.7 | 4.9 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 6.3 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 3.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 7.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.7 | 4.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 58.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 1.4 | GO:0071224 | positive regulation of immature T cell proliferation(GO:0033091) cellular response to peptidoglycan(GO:0071224) |
0.7 | 4.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 2.0 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.7 | 2.7 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.7 | 11.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 2.7 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.7 | 2.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.7 | 2.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.7 | 1.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.7 | 3.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.7 | 4.6 | GO:0019835 | cytolysis(GO:0019835) |
0.7 | 2.0 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.7 | 2.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 2.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.6 | 1.9 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.6 | 98.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 12.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 1.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 1.2 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.6 | 3.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.6 | 2.4 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.6 | 6.7 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.6 | 4.2 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.6 | 2.4 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.6 | 2.4 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.6 | 2.4 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.6 | 14.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.6 | 1.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 4.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 1.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.6 | 2.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 2.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.6 | 4.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.6 | 1.7 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.6 | 1.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.6 | 4.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.6 | 1.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.6 | 1.7 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.5 | 2.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 2.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.5 | 12.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 0.5 | GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
0.5 | 1.6 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.5 | 1.1 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.5 | 1.6 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.5 | 4.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 5.8 | GO:0043383 | negative T cell selection(GO:0043383) |
0.5 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 0.5 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.5 | 1.6 | GO:0072535 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.5 | 2.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.5 | 3.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.5 | 14.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 1.5 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.5 | 1.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
0.5 | 2.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.5 | 4.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 6.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 21.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.5 | 3.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.5 | 0.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.5 | 4.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 2.0 | GO:0034165 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 2.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 2.5 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.5 | 7.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.5 | 6.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.5 | 6.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 1.0 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.5 | 1.4 | GO:0044782 | cilium organization(GO:0044782) |
0.5 | 1.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.5 | 2.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 1.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.5 | 10.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 9.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 3.8 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.5 | 4.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.9 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 0.9 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 8.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 21.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 1.9 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.5 | 40.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.5 | 6.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 2.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.5 | 3.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 1.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.4 | 4.0 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.4 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 7.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.4 | 2.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.4 | 4.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 2.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.4 | 1.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.4 | 73.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 2.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 1.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 4.7 | GO:0072678 | T cell migration(GO:0072678) |
0.4 | 0.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 2.1 | GO:0045629 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) positive regulation of T-helper 1 cell differentiation(GO:0045627) negative regulation of T-helper 2 cell differentiation(GO:0045629) negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.4 | 33.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 0.8 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.4 | 11.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 6.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.4 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.4 | 1.3 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 6.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 2.1 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.4 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 7.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 2.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 5.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 8.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 0.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 3.3 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.4 | 0.4 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.4 | 1.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.4 | 2.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.4 | 11.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 13.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.4 | 1.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 25.2 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.4 | 1.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.4 | 5.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.4 | 32.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 0.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.4 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 1.9 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.4 | 1.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 5.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 1.1 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.4 | 1.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.4 | 0.7 | GO:0002188 | translation reinitiation(GO:0002188) |
0.4 | 3.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 3.0 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 2.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 3.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 3.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 0.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.4 | 0.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.4 | 5.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 5.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.4 | 1.1 | GO:0070839 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.4 | 2.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 2.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.3 | 4.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 5.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 4.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 8.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.3 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 6.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 1.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 0.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 11.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 4.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 1.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.3 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
0.3 | 17.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 1.0 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 2.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.3 | 4.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 8.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 1.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.6 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 2.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 1.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 1.3 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.3 | 0.3 | GO:0021691 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.3 | 2.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 1.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 1.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.3 | 2.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 1.3 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.3 | 1.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.3 | 1.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.6 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 1.2 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.3 | 36.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 0.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 0.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.3 | 3.7 | GO:1903943 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.3 | 1.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 6.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 6.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 0.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 1.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 2.7 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.3 | 11.8 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.3 | 0.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.3 | 1.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 3.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 3.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 5.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.3 | 1.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.3 | 0.3 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.3 | 0.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 5.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.3 | 0.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.8 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.3 | 1.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.3 | 2.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.3 | 1.1 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.3 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 4.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 4.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 1.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.5 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.3 | 1.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 4.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.5 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.3 | 3.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 1.0 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.3 | 0.8 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.3 | 1.0 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.3 | 178.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.3 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.0 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 11.2 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 0.7 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 2.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 1.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.7 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.2 | 2.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.7 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.2 | 3.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 10.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 2.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.2 | 2.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.9 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.2 | 0.7 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 1.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 2.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.2 | 0.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 2.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 2.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 3.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 2.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 0.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 5.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 4.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.8 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 1.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 36.7 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.2 | 0.7 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.2 | 1.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 1.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 2.0 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 3.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.2 | 0.6 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.2 | 3.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 1.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 14.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 7.7 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.2 | 3.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 1.2 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 4.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 1.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 | 1.4 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.6 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.2 | 0.6 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
0.2 | 10.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.2 | 1.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 1.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.8 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 9.6 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
0.2 | 1.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 0.8 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.2 | 0.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 3.2 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.8 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.2 | 0.8 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 4.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 4.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 3.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 7.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.7 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 1.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.4 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
0.2 | 2.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.2 | 1.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 1.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 1.4 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 0.5 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.2 | 0.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.5 | GO:2000767 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 1.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 1.0 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 5.4 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 1.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.2 | 2.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 1.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 4.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.2 | 2.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 5.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 3.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.6 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 2.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 1.4 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 0.3 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.2 | 1.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.6 | GO:0006272 | leading strand elongation(GO:0006272) |
0.2 | 11.4 | GO:0042113 | B cell activation(GO:0042113) |
0.2 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.2 | 6.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.3 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 2.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.9 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 1.1 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.8 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 6.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 1.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:0003257 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 5.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.9 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 3.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 3.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 1.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 9.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 1.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 1.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 5.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 2.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 3.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 3.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 2.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 2.0 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 2.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 2.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 2.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.4 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 1.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 7.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 6.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 1.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 1.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 8.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 2.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 1.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.4 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 0.2 | GO:1904693 | embryonic nail plate morphogenesis(GO:0035880) midbrain morphogenesis(GO:1904693) |
0.1 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.7 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 3.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 2.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 1.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 5.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 3.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 1.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 2.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.2 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.1 | 1.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 3.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 1.8 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 1.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 2.0 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.8 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 1.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.4 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 1.4 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.1 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 6.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 1.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 2.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 1.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.6 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 2.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 1.0 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 1.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 1.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0090135 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) actin filament branching(GO:0090135) |
0.1 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 2.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.8 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.8 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.1 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.1 | 2.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 11.6 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.3 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.1 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.5 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.8 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 1.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.3 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 11.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 1.9 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 7.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 2.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 5.8 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 3.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 2.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 1.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 3.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 2.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.7 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.1 | 2.7 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 3.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.6 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 2.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 0.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 6.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.8 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 2.5 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 3.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 1.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 4.6 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 1.8 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 1.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 4.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.6 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.1 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.4 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.0 | 0.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 7.9 | GO:0050900 | leukocyte migration(GO:0050900) |
0.0 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.6 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.4 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.0 | 0.6 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 3.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 1.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 1.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 3.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.5 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.3 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 2.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.4 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 1.7 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0010878 | cholesterol storage(GO:0010878) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.0 | 31.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.0 | 0.6 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.0 | 1.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.0 | 0.5 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.5 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.5 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.0 | 0.3 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.5 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.0 | 0.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 1.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
0.0 | 0.1 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.0 | 0.9 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 1.2 | GO:0001894 | tissue homeostasis(GO:0001894) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.0 | 0.7 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 1.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.0 | GO:0030474 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.0 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) mRNA 3'-end processing(GO:0031124) |
0.0 | 0.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.3 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.7 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.2 | GO:0014854 | response to inactivity(GO:0014854) |
0.0 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.3 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.2 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.3 | GO:0051646 | mitochondrion localization(GO:0051646) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 28.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
4.0 | 44.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
2.8 | 36.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.0 | 49.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.7 | 11.8 | GO:0044194 | cytolytic granule(GO:0044194) |
1.6 | 16.4 | GO:0032010 | phagolysosome(GO:0032010) |
1.5 | 6.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
1.5 | 6.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.5 | 7.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.4 | 85.1 | GO:0001772 | immunological synapse(GO:0001772) |
1.4 | 4.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
1.4 | 4.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
1.4 | 38.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 7.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.1 | 27.2 | GO:0097342 | ripoptosome(GO:0097342) |
1.1 | 12.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.1 | 7.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.1 | 4.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
1.1 | 6.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.1 | 6.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.1 | 4.2 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 3.0 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.0 | 4.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 2.7 | GO:0097134 | Y chromosome(GO:0000806) cyclin A2-CDK2 complex(GO:0097124) cyclin E1-CDK2 complex(GO:0097134) |
0.9 | 2.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.9 | 2.6 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.8 | 4.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.8 | 3.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.8 | 14.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.8 | 2.5 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.8 | 5.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 5.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.7 | 16.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 80.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.7 | 2.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.7 | 5.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.7 | 21.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 18.6 | GO:0042599 | lamellar body(GO:0042599) |
0.7 | 4.6 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 5.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 12.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 0.6 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.6 | 3.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.6 | 1.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.6 | 51.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 1.8 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.6 | 1.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 45.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.6 | 67.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 1.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 29.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.5 | 2.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 1.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 4.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 2.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.5 | 5.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 3.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 3.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 3.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 3.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 5.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 4.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 4.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 5.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 6.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 3.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 3.0 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.4 | 2.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.4 | 5.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 1.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.4 | 0.8 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.4 | 1.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.4 | 1.5 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 10.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 51.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.4 | 8.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 2.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 119.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 4.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 28.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 1.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.3 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 3.6 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 7.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 6.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 3.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.1 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.9 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.3 | 7.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 11.0 | GO:0031105 | septin complex(GO:0031105) |
0.3 | 67.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 23.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.3 | 1.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 2.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 2.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 1.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 3.6 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.7 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 18.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 2.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.9 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 1.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.8 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.2 | 3.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 2.1 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 1.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 5.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 25.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 1.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 51.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.2 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 6.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 0.7 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 5.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 5.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 1.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 2.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 5.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 30.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 5.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 4.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 3.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 0.5 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 8.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 4.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 2.5 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 2.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 25.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 1.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 3.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 2.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 3.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 7.9 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 4.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 14.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 3.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 17.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 0.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 4.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 2.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 3.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.0 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 6.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 3.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 8.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 2.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 3.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 3.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 6.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 11.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 41.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 2.0 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 3.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 2.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 3.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 2.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 3.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 6.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 1.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 4.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 3.4 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 20.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 7.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 9.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.0 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 6.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 6.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 77.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 7.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 62.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.9 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 1.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 8.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0043601 | nuclear replisome(GO:0043601) |
0.0 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 1.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 124.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 1.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 46.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
3.4 | 30.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
3.0 | 20.9 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
2.7 | 15.9 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
2.6 | 7.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.6 | 15.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
2.4 | 9.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
2.4 | 14.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
2.3 | 6.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
2.2 | 10.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.1 | 10.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.0 | 6.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.9 | 9.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.9 | 5.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.7 | 5.2 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
1.6 | 9.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.5 | 7.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.5 | 12.2 | GO:0005124 | N-formyl peptide receptor activity(GO:0004982) scavenger receptor binding(GO:0005124) |
1.5 | 4.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
1.5 | 7.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.5 | 44.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.4 | 10.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.4 | 4.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
1.4 | 8.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.3 | 16.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.3 | 6.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.3 | 12.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.3 | 7.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.2 | 3.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.2 | 15.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.2 | 4.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.1 | 4.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.1 | 4.6 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
1.1 | 22.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.1 | 7.8 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.1 | 4.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
1.1 | 5.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.1 | 10.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.0 | 6.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 22.5 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 3.0 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
1.0 | 24.9 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 1.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
1.0 | 3.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.0 | 2.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.0 | 1.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.9 | 3.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 6.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 3.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.9 | 8.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 9.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.9 | 6.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.9 | 9.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.9 | 4.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 5.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.8 | 15.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.8 | 2.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 3.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.8 | 6.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.8 | 4.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.8 | 7.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.8 | 4.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.8 | 4.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 3.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.8 | 4.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 0.8 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.8 | 3.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 3.0 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 6.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 1.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.7 | 2.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.7 | 18.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.7 | 2.2 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.7 | 2.2 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.7 | 6.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.7 | 5.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.7 | 4.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.7 | 2.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.7 | 7.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.7 | 2.7 | GO:0008184 | purine nucleobase binding(GO:0002060) glycogen phosphorylase activity(GO:0008184) |
0.7 | 9.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 10.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 3.4 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 2.7 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.7 | 5.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 26.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.7 | 11.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 46.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 1.9 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.6 | 8.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 7.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 17.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 5.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 8.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.6 | 6.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 4.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 1.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.6 | 17.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 4.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 3.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 1.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.6 | 7.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.7 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.6 | 1.7 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
0.6 | 25.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 3.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.6 | 131.7 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 0.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.5 | 9.8 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.5 | 2.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 2.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.5 | 3.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.5 | 3.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.5 | 54.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 4.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 2.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.5 | 20.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 1.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 2.5 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.5 | 3.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 1.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
0.5 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.5 | 7.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 4.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.5 | 0.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.5 | 1.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 1.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.5 | 8.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.3 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.5 | 5.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 4.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.4 | 1.3 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.4 | 4.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 2.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.4 | 1.3 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.4 | 2.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 9.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 1.6 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.4 | 2.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 4.9 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 26.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 2.0 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 2.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 2.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 9.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.4 | 5.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.4 | 14.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 14.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.4 | 11.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 1.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 7.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 11.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.4 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 6.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 4.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 3.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 1.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.4 | 1.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.4 | 2.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.4 | 1.1 | GO:0097689 | iron channel activity(GO:0097689) |
0.4 | 1.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 3.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 10.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 13.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 4.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 2.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.3 | 2.7 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 6.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 5.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 3.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.3 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 7.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 2.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 3.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 14.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 1.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 5.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 0.9 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.3 | 1.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 3.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 9.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 0.9 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.3 | 3.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 0.9 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 2.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 7.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.3 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.3 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 4.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.5 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.3 | 2.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 2.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 2.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 3.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 0.8 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.3 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.0 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 6.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.2 | 7.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 12.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.2 | 1.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 48.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.9 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 1.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 9.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 19.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.6 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.2 | 3.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.9 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 3.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 1.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 1.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 4.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.6 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.2 | 7.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 2.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 9.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 2.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 10.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 3.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.8 | GO:0050473 | linoleate 13S-lipoxygenase activity(GO:0016165) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.2 | 0.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 0.6 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.2 | 0.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 1.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 34.5 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 3.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 10.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 4.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 6.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 2.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.9 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 15.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 2.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 84.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 1.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 5.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 12.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 4.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 5.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 3.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 2.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 15.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 17.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 2.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.8 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 9.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 0.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 2.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 3.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 8.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 3.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 3.1 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 3.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 1.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.7 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 3.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 2.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 2.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 2.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.5 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 7.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.1 | 4.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 5.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.4 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 48.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 5.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 4.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.8 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 4.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 6.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 1.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.2 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.1 | 1.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.6 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.1 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 2.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 2.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 3.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 20.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 4.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.7 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 3.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 55.8 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.1 | 2.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 5.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 7.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 1.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 2.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.1 | 3.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 12.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 15.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 5.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 5.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.3 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.1 | 1.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 11.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 1.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 2.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 1.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.3 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 1.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.2 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 2.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 3.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 2.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 20.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 3.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 3.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 1.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 1.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 3.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 1.6 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 3.1 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.0 | 0.6 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 190.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.5 | 1.5 | ST STAT3 PATHWAY | STAT3 Pathway |
1.2 | 84.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.1 | 50.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.0 | 24.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 12.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 48.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 40.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.8 | 5.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 20.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 28.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 23.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 23.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 23.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 56.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 11.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 67.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 15.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 10.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 6.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 5.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 21.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 14.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 9.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 11.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 24.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 4.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 6.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 19.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 6.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 9.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.3 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 4.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 10.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 4.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 9.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 13.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 13.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 4.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 9.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 17.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 6.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 46.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 5.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 12.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 9.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 7.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 5.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 5.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 8.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 5.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 42.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 4.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 6.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 4.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 5.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 3.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 14.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 4.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 6.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 6.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 3.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 4.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 6.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 97.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.3 | 9.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.5 | 182.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.4 | 4.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.2 | 2.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.1 | 11.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.1 | 41.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 19.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 22.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.9 | 8.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.9 | 29.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.9 | 20.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.9 | 18.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 59.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 3.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 54.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 61.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.7 | 5.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.7 | 8.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 8.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 68.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 5.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 11.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 4.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 20.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 11.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.6 | 16.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 15.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 12.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 3.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 3.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 26.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 9.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.4 | 39.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 10.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 11.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 21.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 6.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 5.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 2.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 4.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 3.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 20.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 2.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 2.3 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.3 | 4.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 2.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 7.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 8.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 80.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 7.8 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 2.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 1.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 6.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 4.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 12.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 9.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 5.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 12.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 10.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 11.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 8.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 12.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 6.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 7.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 12.2 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 2.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 7.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 6.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 2.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 30.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 6.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 6.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 3.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 3.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 11.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 4.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 3.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 5.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 6.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 13.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 5.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 9.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 16.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 8.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 5.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 5.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 1.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 2.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |